Last reviewed · How we verify
NCT04168372
Fructose: Substrate, Stimulus, or Both?
NA trial testing High fructose, fructose labeled meal in Insulin Resistance in 35 participants. Completed in 20 November 2024.
20 November 2024
Quick facts
| Lead sponsor | Touro University, California |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 35 |
| Start date | 15 September 2019 |
| Primary completion | 20 November 2024 |
| Estimated completion | 20 November 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- High fructose, fructose labeled meal
- High fructose, pyruvate labeled meal
- Low fructose, fructose labeled meal
- Low fructose, pyruvate labeled meal
Conditions studied
- Insulin Resistance — all drugs for Insulin Resistance →
- Insulin Sensitivity — all drugs for Insulin Sensitivity →
- Pre Diabetes — all drugs for Pre Diabetes →
Sponsor
Touro University, California
Who can join
Adults 20 to 55, any sex, with Insulin Resistance or Insulin Sensitivity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This objective of this study is to use sensitive methodology under controlled conditions to investigate the mechanisms by which fructose consumption contributes to excess fatty acid synthesis and elevations in blood glucose levels following consumption of meals containing fructose.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04168372
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Insulin Resistance
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
- NCT07505745 — MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity · Phase 2 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06768827 — New Mechanisms of Obesity · NA · recruiting
Other Touro University, California trials
Trials by the same sponsor.
- NCT07306013 — The SolanoConnex Trial: Evaluation of a Mental Health Access Project · NA · recruiting
- NCT03901014 — Investigating the Production of Lipoproteins and Acetyl-CoA During a Ketogenic Diet · NA · completed
- NCT03117842 — Using a Theory-based SMS/VM Intervention to Improve Sexual and Reproductive Health of Female Entertainment Workers in Ca · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04168372 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Touro University, California
- Last refreshed: 10 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04168372.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing